3Rodriguez L V, Terris M I L. Risks and complications of transrectal ultrasound guided prostate biopsy; A prospective study and review of the literature[J]. Urol, 1998, 160(2): 2115.
4Thompson P M, Prior J P, Williams J P, et al. The problem of infection after prostatic biopsy: the case for the transperineal approach[J]. BrJ Urol, 1982, 54(8): 736.
5Feliciano J, Teper E, Ferrandino M, et al. The incidence of fluoroquinolone resistant infections after prostate biopsy-are fluoroquinolones still effective prophylaxis.9 J Uro! 2008; 179(3): 952-955.
6Lindstedt S, Lindstr6m U, Ljunggren E, et al. Single- dose antibiotic prophylaxis in core prostate biopsy: impact of timing and identification of risk factors. Eur Urol 2006; 50 (4): 832-837.
7Aus G, Ahlgren G, Bergdahl S, et al. Infection after transrectal core biopsies of the prostate-risk factors and antibiotic prophylaxis. Br J Urol 1996; 77(6): 851-855.
8Wolfson JS, Hooper DC. Treatment of genitourinary tract infections with fluoroquinolones: activity in vitro, pharmacokinetics, and clinical efficacy in urinary tract infection and prostatitis.Antimicrob Agents Chemother 1989; 33(10): 1655-1661.
9Taylor HM, Bingham JB. The use of prophylactic antibiotics in ultrasound-guided transrectal prostate biopsy. Clin Radio1 1997; 52(10): 787-790.
10Davis M, Sofer M, Kim SS, etal. The procedure oftransrectal ultrasound guided biopsy of the prostate: a survey of patient preparation and biopsy technique. J Urol 2002; 167(2 pt 1): 566-570.
